Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DXS InternationalAQSE:DXSP Earnings per Share (Diluted) is £-0.00 as of Apr. 2025. The stock has 5 warning signs investors should review. Among 503 Healthcare Providers & Services companies, DXS International ranks worse than 198806.96% on this metric.
DXS International's EPS (Basic) for the
six
months ended in Apr. 2025 was £-0.00.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2025 was £-0.00.
During the past 11 years, DXS International's highest 3-Year average EPS without NRI Growth Rate was 49.40% per year. The lowest was -30.70% per year. And the median was -0.35% per year.
DXS International (AQSE:DXSP) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
DXS International Earnings per Share (Diluted) Related Terms
DXS International Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for DXS International's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DXS International Earnings per Share (Diluted) Chart
AQSE:DXSP vs VEEV, BTSG, TEM: Earnings per Share (Diluted) Comparison
For the Health Information Services subindustry, DXS International's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DXS International PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DXS International's PE Ratio distribution charts can be found below:
* The bar in red indicates where DXS International's PE Ratio falls into.
DXS International Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
DXS International's Earnings Per Share (Diluted) for the fiscal year that ended in Apr. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of £-0.00 mean?
DXS International (AQSE:DXSP) has a Earnings per Share (Diluted) of £-0.00 as of Apr. 2025. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on DXS International and its competitors. According to the industry distribution chart, DXS International ranks #999999 out of 503 companies in the Healthcare Providers & Services industry.
Is DXS International's Earnings per Share (Diluted) too high?
DXS International's current Earnings per Share (Diluted) is £-0.00. Based on the distribution chart, DXS International ranks #999999 out of 503 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does DXS International's Earnings per Share (Diluted) compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DXS International ranks #999999 out of 503 companies for Earnings per Share (Diluted). This places DXS International in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.00, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on DXS International and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DXS International's current Earnings per Share (Diluted) is £-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Fairly Valued. The stock's GF Value™ is £0.02, compared to a current price of £0.02 — trading 5% above its estimated fair value. The current Earnings per Share (Diluted) is £-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current Earnings per Share (Diluted) is £-0.00 as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQSE:DXSP has been successfully added to your 
